Daniel Pollard
MSc
Population Health, School of Medicine and Population Health
Lecturer
+44 114 222 6126
Full contact details
Population Health, School of Medicine and Population Health
Regent Court (ScHARR)
30 Regent Street
91̽»¨
S1 4DA
- Profile
-
I joined HEDS in December 2013 as a Research Assistant. Prior to this I studied at the University of York, completing my MSc in Health Economics in 2013 and my BSc(Hons) in Economics in 2012. Since joining HEDs I have been involved in the modelling projects in many different disease areas, including diabetes, oncology and emergency medicine.
- Research interests
-
My research involves conducting health economic evaluations of new strategies to improve the health of people with specific conditions. My most commonly used methods to do this involve using individual level simulation models to estimate differences in costs and benefits over a lifetime horizon. Although I have used other techniques, e.g. cohort models and analysis of cost and benefits within a study when this appropriate.
The most common disease area I do research in is the evaluation of strategies to improve the health of people with either type 1 or type 2 diabetes. But I have worked across a number of disease areas, including, but not limited to, emergency medicine, oncology, gastroenterology and cardiology.
- Publications
-
Show: Featured publications All publications
Featured publications
Journal articles
- . BMC Emergency Medicine, 22.
- . BMJ Open, 11(1).
- . Value in Health.
- . Health Technology Assessment, 24(28).
- . Health Technology Assessment, 22(47).
- . Value in Health.
- . BMJ Open, 8(4).
- . International Journal of Technology Assessment in Health Care, 32(4), 203-211.
- . PharmacoEconomics, 34(5), 463-477.
- . Medical Decision Making, 0272989X2110654-0272989X2110654.
All publications
Journal articles
- . The Lancet, 402, S75-S75.
- . PLoS ONE, 18(3).
- . BMJ Open, 12(2).
- . BMC Emergency Medicine, 22.
- . Health technology assessment (Winchester, England), 25(77), 1-190.
- . BMC Med, 19(1), 130.
- . BMC Health Services Research, 21.
- . BMJ Open, 11(1).
- . Value in Health.
- . Health Technology Assessment, 24(28).
- . BMJ Open Diabetes Research & Care, 8(1).
- . Diabetic Medicine.
- . PharmacoEconomics.
- . Health Technology Assessment, 22(47).
- . Value in Health.
- . BMJ Open, 8(4).
- . Health Technology Assessment, 21(20), 1-278.
- . BMJ, 356.
- . International Journal of Technology Assessment in Health Care, 32(4), 203-211.
- . PharmacoEconomics, 34(5), 463-477.
- . Medical Decision Making, 35(7), 872-887.
- . Advances in Therapy.
- A cost-effectiveness analysis of two interventions to promote physical activity in a multi-ethnic population at high risk of diabetes: an economic evaluation of the 48 month PROPELS Randomised Controlled Trial. BMJ Open Diabetes Research and Care.
- Hypo-METRICS: Hypoglycaemia – MEasurement, ThResholds and ImpaCtS – A multi-country clinical study to define the optimal threshold and duration of sensor-detected hypoglycaemia that impact the experience of hypoglycaemia, quality of life and health economic outcomes: the study protocol. Diabetic Medicine.
- . Medical Decision Making, 0272989X2110654-0272989X2110654.
Conference proceedings papers
- IMPACT OF NOCTURNAL SYMPTOMATIC AND ASYMPTOMATIC PERSON-REPORTED HYPOGLYCAEMIA ON MORNING FUNCTIONING AMONG ADULTS WITH INSULIN-TREATED DIABETES: THE HYPO-METRICS STUDY. DIABETES TECHNOLOGY & THERAPEUTICS, Vol. 25 (pp A266-A267)
- . Diabetes, Vol. 71(Supplement_1)
- . Value in Health, Vol. 22 (pp S584-S584)
- . Value in Health, Vol. 22 (pp S577-S577)
- PRETRIAL MODELLING METHODS TO JUSTIFY AND INFORM THE DESIGN OF LARGE RCTS - EXPECTED VALUE OF SAMPLE INFORMATION FOR THE DAFNEPLUS DIABETES EDUCATION CLUSTER RCT. VALUE IN HEALTH, Vol. 22 (pp S584-S584)
- A HEALTH ECONOMIC AND DECISION MODELLING ANALYSIS PLAN FOR AN INTEGRATED DATABASE OF OVER 100 CLINICAL TRIALS MEASURING HYPOGLYCAEMIC ATTACKS FOR PEOPLE WITH DIABETES: A HEDMAP FOR HYPORESOLVE. VALUE IN HEALTH, Vol. 22 (pp S577-S577)
- . Emergency Medicine Journal, Vol. 34(12) (pp A867-A868)
- EXPECTED VALUE OF SAMPLE INFORMATION FOR INDIVIDUAL LEVEL SIMULATION MODELS TO INFORM STOP/GO DECISION MAKING BY PUBLIC RESEARCH FUNDERS: A METHODOLOGY FOR THE DAFNEPLUS DIABETES EDUCATION CLUSTER RCT. VALUE IN HEALTH, Vol. 20(9) (pp A776-A776)
- . Value in Health, Vol. 17(7) (pp A350-A350)
- . Endocrine Abstracts
Reports
- Pre-read document 1: Challenges in valuing and paying for combination regimens in oncology
- Generic Cancer Screen - Economic modelling report
Preprints
- Teaching interests
-
My teaching interest revolve around the principles behind conducting economic evaluation of health technologies, how to build economic models to assess health technologies and statistical techniques that can inform economic assessments.
- Teaching activities
-
I am the module leader on HAR 672, advanced simulation methods. I am the deputy module leader on HAR6260: Economic Evaluation and HAR6167: Cost-effectiveness Modelling for Health Technology Assessment. I also coordinate the module HAR6178: Further Statistical Methods for Health Economic Analysis.
Links